Theater group performs piece slamming drug war at Luneta rally | Inquirer News

Theater group performs piece slamming drug war at Luneta rally

By: - Reporter / @JhoannaBINQ
/ 07:54 PM September 21, 2017

The Philippine Educational Theater Association (Peta) has proved once again it was worthy of the Ramon Magsaysay Award as they blasted the police’s alleged quota under the government’s war on drugs through their new song.

The group performed at the Luneta Park rally that denounced the increasing human rights violations in the country.

Article continues after this advertisement

In their jazzy song entitled “Quota,” Peta took swipe on the Philippine National Police’s (PNP) reported quota or target number of killing drug suspects.

FEATURED STORIES

“Meron quota, quota, kailangan pa ng quota. Basta may mapagbubuntunan, tapos kunwari nanlaban!” the group sang.

(There’s a quota, quota, we need to have a quota. Just as long as we can dump it all on someone and pretend they fought back!)

Article continues after this advertisement

Clad in black, Peta members also denounced the House of Representatives’ move to fund the Commission on Human Rights (CHR) with a measly P1,000.

Peta was awarded this year’s Ramon Magsaysay Award, dubbed as Asia’s equivalent of the Nobel Prize. The group, according to the Ramon Magsaysay Foundation, has greatly contributed in shaping theater arts in the Philippines as a force for social change. /je

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Drug war, Luneta Park, Performance, PETA, protest, quota, rally, theater

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.